Works matching IS 21644403 AND DT 2018 AND VI 8 AND IP 10
Results: 32
CAR T-Cell Therapy Yields Impressive Responses in Aggressive Non-Hodgkin Lymphoma.
- Published in:
- Oncology Practice Management, 2018, v. 8, n. 10, p. 14
- By:
- Publication type:
- Article
Investigational CAR T-Cell Therapy, bb2121, Shows Durable Responses in Relapsed or Refractory Multiple Myeloma.
- Published in:
- Oncology Practice Management, 2018, v. 8, n. 10, p. 16
- By:
- Publication type:
- Article
Immunotherapy Combinations "Raising the Bar".
- Published in:
- Oncology Practice Management, 2018, v. 8, n. 10, p. 11
- By:
- Publication type:
- Article
Oral Toxicities Associated with Cancer Therapies: What's Old Is New Again.
- Published in:
- Oncology Practice Management, 2018, v. 8, n. 10, p. 1
- By:
- Publication type:
- Article
Entrectinib Active in ROS1-Positive Non-Small-Cell Lung Cancer and Brain Metastases.
- Published in:
- Oncology Practice Management, 2018, v. 8, n. 10, p. 32
- By:
- Publication type:
- Article
PACIFIC: Practice-Changing Study in Stage III Unresectable Non-Small-Cell Lung Cancer.
- Published in:
- Oncology Practice Management, 2018, v. 8, n. 10, p. 28
- By:
- Publication type:
- Article
New First-Line Regimen for Small-Cell Lung Cancer: Atezolizumab plus Chemotherapy.
- Published in:
- Oncology Practice Management, 2018, v. 8, n. 10, p. 29
- By:
- Publication type:
- Article
Libtayo First Immunotherapy Approved for Advanced Cutaneous Squamous-Cell Carcinoma.
- Published in:
- Oncology Practice Management, 2018, v. 8, n. 10, p. 23
- Publication type:
- Article
FDA Approves Expanded Use of HPV Vaccine Gardasil 9.
- Published in:
- Oncology Practice Management, 2018, v. 8, n. 10, p. 24
- Publication type:
- Article
Vizimpro a New First-Line Targeted Therapy for Metastatic NSCLC with EGFR Mutations.
- Published in:
- Oncology Practice Management, 2018, v. 8, n. 10, p. 23
- Publication type:
- Article
Lumoxiti a New Treatment Approved for Patients with Hairy-Cell Leukemia.
- Published in:
- Oncology Practice Management, 2018, v. 8, n. 10, p. 22
- Publication type:
- Article
Poteligeo Approved for 2 Rare Types of Non-Hodgkin Lymphoma.
- Published in:
- Oncology Practice Management, 2018, v. 8, n. 10, p. 22
- Publication type:
- Article
NCCN Drug Affordability Ratings Miss the Mark in Lung Cancer.
- Published in:
- Oncology Practice Management, 2018, v. 8, n. 10, p. 20
- By:
- Publication type:
- Article
Managing Bone Metastases Through a Multidisciplinary Approach.
- Published in:
- Oncology Practice Management, 2018, v. 8, n. 10, p. 17
- By:
- Publication type:
- Article
Practice-Changing Results: Adding Immunotherapy to Chemotherapy Extends Survival in Metastatic Triple-Negative Breast Cancer.
- Published in:
- Oncology Practice Management, 2018, v. 8, n. 10, p. 1
- By:
- Publication type:
- Article
Managing Anxiety in Patients with Advanced Cancer.
- Published in:
- Oncology Practice Management, 2018, v. 8, n. 10, p. 1
- By:
- Publication type:
- Article
FDA Updates the Indications for Tecentriq and Keytruda in Urothelial Cancer.
- Published in:
- Oncology Practice Management, 2018, v. 8, n. 10, p. 34
- Publication type:
- Article
Tabelecleucel Shows High Response Rates in Patients with EBV-Associated Posttransplant Lymphoma Refractory to Rituximab.
- Published in:
- Oncology Practice Management, 2018, v. 8, n. 10, p. 29
- By:
- Publication type:
- Article
Omega-3 Fatty Acids Significantly Reduced Pain in Obese Patients with Breast Cancer.
- Published in:
- Oncology Practice Management, 2018, v. 8, n. 10, p. 26
- By:
- Publication type:
- Article
Opdivo Approved for Patients with Metastatic Small-Cell Lung Cancer.
- Published in:
- Oncology Practice Management, 2018, v. 8, n. 10, p. 34
- Publication type:
- Article
Lenvima Now Approved for Unresectable Hepatocellular Carcinoma.
- Published in:
- Oncology Practice Management, 2018, v. 8, n. 10, p. 34
- Publication type:
- Article
Kisqali Receives Expanded Indications for HR-Positive, HER2-Negative Advanced or Metastatic Breast Cancer.
- Published in:
- Oncology Practice Management, 2018, v. 8, n. 10, p. 33
- Publication type:
- Article
Tibsovo First-in-Class IDH1 Inhibitor for Relapsed or Refractory Acute Myeloid Leukemia with IDH1 Mutation.
- Published in:
- Oncology Practice Management, 2018, v. 8, n. 10, p. 32
- Publication type:
- Article
Xtandi Now Indicated for Nonmetastatic Castration-Resistant Prostate Cancer.
- Published in:
- Oncology Practice Management, 2018, v. 8, n. 10, p. 33
- Publication type:
- Article
Opdivo plus Yervoy Approved for MSI-H or dMMR Colorectal Cancer.
- Published in:
- Oncology Practice Management, 2018, v. 8, n. 10, p. 33
- Publication type:
- Article
Braftovi plus Mektovi a New Combination for Unresectable or Metastatic Melanoma with BRAF Mutation.
- Published in:
- Oncology Practice Management, 2018, v. 8, n. 10, p. 32
- Publication type:
- Article
High Rates of Sleep Deficiency and Cancer-Related Fatigue Across Diagnoses.
- Published in:
- Oncology Practice Management, 2018, v. 8, n. 10, p. 24
- By:
- Publication type:
- Article
Oncology Practice Landscape in 2018: ASCO Survey Shows Interactions with Payers Top Concern.
- Published in:
- Oncology Practice Management, 2018, v. 8, n. 10, p. 20
- By:
- Publication type:
- Article
Oncology Community Raising Concerns About Utilization Management, PBMs.
- Published in:
- Oncology Practice Management, 2018, v. 8, n. 10, p. 17
- By:
- Publication type:
- Article
Cognitive Behavioral Therapy More Effective Than Acupuncture for Mild Insomnia in Cancer Survivors.
- Published in:
- Oncology Practice Management, 2018, v. 8, n. 10, p. 1
- By:
- Publication type:
- Article
What Does the Future Hold for PBMs? Implications for Oncology Practices.
- Published in:
- Oncology Practice Management, 2018, v. 8, n. 10, p. 1
- By:
- Publication type:
- Article
FDA Commissioner Outlines New Plan to Increase Biosimilars by "Balancing Innovation and Competition".
- Published in:
- Oncology Practice Management, 2018, v. 8, n. 10, p. 1
- By:
- Publication type:
- Article